$16.90
+0.87 (+5.43%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Price Target
Analyst Price Target
+46.1% upside
Low Target
$14.59
Average Target
$24.69
High Target
$25.91
Current Price
$16.90
Current
$16.90
$16.90
Target
$24.69
$24.69
$14.59
$24.69 avg
$25.91
Scenario Analysis
Bear Case
$14.59
-13.7%
Low target
Base Case
$24.69
+46.1%
Avg target
Bull Case
$25.91
+53.3%
High target
Risk/Reward
3.9x
Highly favorable
Price in Context
52-Week High
$16.86
0.2% from high
52-Week Low
$5.06
+234.0% from low
Target vs 52W High
$24.69
+46.4% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -0.5% |
| AMGN | Hold | 43 | 49% | $190.87 | -55.1% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +152.8% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -17.0% |
| REGN | Buy | 37 | 70% | $76.80 | -90.5% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -54.1% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -47.2% |
| BIIB | Buy | 43 | 67% | $91.45 | -57.0% |